Nanotechnology Now - News Story: Capsulution is Starting In-vivo Tests at Charité

Home > News > Capsulution is Starting In-vivo Tests at Charité

September 18th, 2006

Capsulution is Starting In-vivo Tests at Charité

Abstract:
The nanotechnology company Capsulution NanoScience AG (Berlin, Germany) has begun with pre-clinical in-vivo tests of innovative formulations of a hormone compound for tumor therapy.

Source:
pressebox.de

Bookmark:

Related Links

Capsulution NanoScience

Related News Press

Nanomedicine

New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025

New imaging approach transforms study of bacterial biofilms August 8th, 2025

Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Announcements

Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026

COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026

Breathing new life into nanotubes for a cooler planet:Researchers at Skoltech discover a simple, single-step heat treatment that nearly doubles the CO2-trapping power of carbon nanotubes January 30th, 2026

New light-based nanotechnology could enable more precise, less harmful cancer treatment: The approach offers a potential alternative to chemotherapy and radiation by using light and heat to target cancer cells. January 30th, 2026



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE